Try our Advanced Search for more refined results

August 29, 2011

In re Google Inc. Shareholder Derivative Litigation

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 08, 2014

    Google To Spend $250M To End Investor Suit Over Pharma Ads

    Google Inc. has agreed to spend a total of $250 million on product quality control to end a suit brought by shareholders after its $500 million settlement with the U.S. government for allowing Canadian pharmaceutical companies to advertise on its site, according to documents filed in California federal court Thursday.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login